Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Published:2015-12 Issue:12 Volume:15 Page:1398-1408
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

O'Brien Katherine L,Chandran Aruna,Weatherholtz Robert,Jafri Hasan S,Griffin M Pamela,Bellamy Terramika,Millar Eugene V,Jensen Kathryn M,Harris Brian S,Reid Raymond,Moulton Lawrence H,Losonsky Genevieve A,Karron Ruth A,Santosham Mathuram

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference29 articles.

1. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases;Paramore;Pharmacoeconomics,2004

2. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;Nair;Lancet,2010

3. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid;Boyce;J Pediatr,2000

4. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience;Moler;Crit Care Med,1992

5. Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes;Horn;J Pediatr,2003

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early-life respiratory syncytial virus disease and long-term respiratory health;The Lancet Respiratory Medicine;2024-09

2. Respiratory syncytial virus infections in adults: a narrative review;The Lancet Respiratory Medicine;2024-09

3. Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development;Reviews in Medical Virology;2024-08-29

4. Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults;The Journal of Infectious Diseases;2024-06-18

5. Infecciones respiratorias víricas de las vías aéreas inferiores: bronquiolitis;EMC - Pediatría;2024-06